Inscription Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Inscription Capital's LLY Position: Q2 2026 in Review
Inscription Capital increased its Eli Lilly (LLY) stake by 50% in Q2 2026, buying an estimated $1.42M and bringing the position to 4,139 shares worth $4.96M. The position accounts for 0.44% of the portfolio, ranked #39.
Inscription Capital first reported a position in LLY in Q2 2021 and has held it in 19 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Inscription Capital held 4,139 shares of Eli Lilly worth $4.96M as of Q2 2026.
- Inscription Capital bought 1,385 Eli Lilly shares in Q2 2026, an estimated $1.42M.
- Eli Lilly made up 0.44% of Inscription Capital's portfolio in Q2 2026, its #39 holding.
- Inscription Capital first reported a position in Eli Lilly in Q2 2021 and has held it in 19 quarters since.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.